Skip to main content
. 2019 Sep 24;10:2281. doi: 10.3389/fimmu.2019.02281

Figure 4.

Figure 4

Double validation of hsa_circ_0000479 as an SLE diagnosis marker in two additional cohorts. (A) Expression of hsa_circ_0000479 in the validation-phase cohort with 23 SLE patients (including the active group and the stable group) and 21 HCs. (B) Expression of hsa_circ_0000479 in the external validation phase cohort with 64 SLE patients (including the active group and the stable group), 58 HCs, and 50 RA patients. Data are presented as a box plot. The “°” and “*,” respectively, indicate data that are more than 1.5-fold and 3-fold the quartile distance from the upper or lower bounds of the box. (C,D) Receiver operating characteristic (ROC) curves of hsa_circ_0000479 in the validation-phase and external validation-phase cohorts for SLE diagnosis.